Haemonetics | HAE - Debt

Stock Price
56.29
Daily Change
-0.83 -1.45%
Monthly
-6.36%
Yearly
-19.94%
Q2 Forecast
55.16

Haemonetics reported $1.22B in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
Avanos Medical USD 129.1M 4.6M Dec/2025
Baxter International USD 9.78B 68M Dec/2025
Becton, Dickinson and Co. USD 19.54B 358M Dec/2025
Boston Scientific USD 11.44B 610M Dec/2025
Cerus USD 84.16M 791K Dec/2024
Cooper Companies USD 2.51B 27M Sep/2025
Fresenius EUR 11.93B 919M Dec/2025
Fresenius Medical Care EUR 11.03B 233.8M Mar/2026
Globus Medical USD 118.66M 687K Dec/2025
Haemonetics USD 1.22B 5K Dec/2025
ICU Medical USD 1.28B 79.88M Dec/2025
Intuitive Surgical USD 0 0 Mar/2025
Masimo USD 485.9M 100.3M Mar/2026
Medtronic USD 28.07B 1.03B Dec/2025
Merit Medical Systems USD 821.57M 420K Dec/2025
Neogen USD 792.93M 396K Sep/2025
OraSure Technologies USD 782K 465K Jun/2024
Plus Therapeutics USD 3.98M 372K Dec/2023
Quidel USD 2.83B 9.9M Dec/2025
ResMed USD 847.72M 1.37M Dec/2025
STAAR Surgical USD 38.35M 764K Dec/2025
Steris USD 2.05B 4.8M Dec/2025
Stryker USD 14.22B 635M Mar/2026
Surmodics USD 29.55M 111K Sep/2024
Teleflex USD 2.73B 43.5M Dec/2025
Terumo JPY 159.87B 14.97B Sep/2025
Thermo Fisher Scientific USD 39.39B 3.7B Dec/2025
US Physical Therapy USD 204.84M 42.38M Mar/2026
Zimmer Biomet Holdings USD 7.47B 48.1M Mar/2026